Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease

The effect of erythropoiesis-stimulating agent (ESA) on dialysis initiation in advanced chronic kidney disease (CKD) patients is not clear. We retrospectively analyzed the outcome of dialysis initiation in a stage 5 CKD cohort with ESA reimbursement limited to the maximal standardized monthly ESA do...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Szu-Yu, Chiang, Wen-Chih, Chen, Ping-Min, Liu, Heng-Hsiu, Chou, Yu-Hsiang, Lai, Tai-Shuan, Lai, Chun-Fu, Chiu, Yen-Ling, Lin, Wan-Yu, Chen, Yung-Ming, Chu, Tzong-Shinn, Lin, Shuei-Liong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341043/
https://www.ncbi.nlm.nih.gov/pubmed/28272424
http://dx.doi.org/10.1038/srep44013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341043/
https://www.ncbi.nlm.nih.gov/pubmed/28272424
http://dx.doi.org/10.1038/srep44013

Ejemplares similares